• Pharma
  • July 1, 2025
  • 132 views
Alembic Pharma surges over 12% on USFDA approval for Cancer drug

Shares of Alembic Pharmaceuticals soared more than 12 percent in intra-day trade on Monday, June 30, after the company announced that it had secured final approval from the US Food…